期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
DNA-guided hepatitis B treatment,viral load is essential,but not sufficient 被引量:8
1
作者 Rafael Bárcena Marugán Silvia García Garzón 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第4期423-430,共8页
Hepatitis B virus (HBV) infection is a global public health problem that concerns 350 million people worldwide. Individuals with chronic hepatitis B (CriB) are at increased risk of developing liver cirrhosis, hepa... Hepatitis B virus (HBV) infection is a global public health problem that concerns 350 million people worldwide. Individuals with chronic hepatitis B (CriB) are at increased risk of developing liver cirrhosis, hepatic de-compensation and hepatocellular carcinoma. To maintain undetectable viral load reduces chronic infection complications. There is no treatment that eradicates HBV infection. Current drugs are expensive, are associated with adverse events, and are of limited efficacy. Current guidelines try to standardize the clinical practice. Nevertheless, controversy remains about management of asymptomatic patients with CriB who are hepatitis B e antigen (HBeAg)-positive with normal alanine aminotransferase, and what is the cut-off value of viral load to distinguish HBeAg- negative CriB patients and inactive carriers. We discuss in detail why DNA level alone is not sufficient to begin treatment of CriB. 展开更多
关键词 Hepatitis B virus Viral DNA Alaninetransaminase antiviral drug Hepatitis B e antigen antiviral drug resistance
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部